What question did this study set out to answer?

To evaluate safety indicators associated with radiotherapy treatments for hepatocellular carcinoma.

February 11, 2026

Exploration of safety indicators for radiotherapy in hepatocellular carcinoma: A real-world study.

Key Points

To evaluate safety indicators associated with radiotherapy treatments for hepatocellular carcinoma.
Real-world observational study design
Comparison of various safety indicators like rRFLV and MLD
Monitoring concurrent antiviral therapy outcomes
EBRT proves safe and effective for HCC across stages
rRFLV metrics show reliability over MLD and RLV for assessing RILDs
Concurrent antiviral therapy appears safe with careful monitoring of serum viral load

Abstract

EBRT is safe and effective for HCC patients at different stages. Compared with MLD and RLV, rRFLVx and rRFLVx/SLV may be more reliable for evaluating the occurrence of RILDs after IMRT treatment. For patients with hepatitis background, concurrent antiviral therapy during radiotherapy is relatively safe, but serum viral load should be closely monitored. Further research is needed to explore the efficacy and safety of radiotherapy combined with targeted and immunotherapy.

AIに質問

Bookmark

Cite This Study

Xie et al. (Tue,) studied this question.

synapsesocial.com/papers/698c1c33267fb587c655e76e https://doi.org/https://doi.org/10.11817/j.issn.1672-7347.2025.250218

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AIに質問

Bookmark